Yuan Goessi: One Bleed Is One Too Many for a Lifetime of Haemophilia A
Yuan Goessi, Digital Marketing Intern at Roche, shared a post on LinkedIn:
“At the heart of every discussion about the future of haemophilia A is the recognition that redefining care goes beyond medicine – it is about looking at patients’ whole lives, protecting joint health, and easing the daily anxieties that families carry across generations.
At Roche, we believe that even one bleed is one too many, especially for a condition like haemophilia A that is for life.
We are profoundly grateful to the dedicated clinicians, researchers, and patient organisations who partner with us every day.
Together, we are raising the bar to turn scientific progress into a new reality.
Find out more about our efforts in haemophilia A on our website.”
Procees to the video attached to the post.
Stay updated with Hemostasis Today.
-
Sep 1, 2026, 18:13Ramsha Batool: Chemotherapy-Induced Anemia Impacts Quality of Life in Breast Cancer
-
Sep 1, 2026, 18:09Natalya Shynhera: Using Anemia to Teach Medical English in Real Clinical Practice
-
Sep 1, 2026, 18:06Wei Du: New Therapeutic Potential for PARP Inhibitors in MLL-Rearranged Leukemia
-
Sep 1, 2026, 18:03Tobias Tichelbäcker: PRAGUE-26 Shows Catheter Lysis Beats Anticoagulation Without Ultrasound
-
Sep 1, 2026, 18:00Baptiste Thibault: My First Publication as First Author on Ionized Calcium Monitoring Before Citrate-CRRT
-
Sep 1, 2026, 17:51Nadezhda Vasilyeva: Shifting the Boundaries of Acute Ischemic Stroke Management
-
Sep 1, 2026, 17:49Malik Ghannam: Recent Venous Thrombosis Risk Factors May Help Explain Cryptogenic Stroke in Young Adults
-
Sep 1, 2026, 17:42Rishabh Jain: Renal Artery FMD Is Managed With Balloon Angioplasty Alone
-
Sep 1, 2026, 17:42Caitlin R: The Brain’s Need to Find Patterns